Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-07-09
2000-07-11
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 14, 514 13, 514 12, 514 17, 514 9, 514806, A61K 3816
Patent
active
06087337&
ABSTRACT:
A method of treating a mammal suffering from benign or malignant proliferative skin disease, e.g., melanoma or malignant skin metastases of melanoma, by topically administering to the mammal at the site of said diseased skin an effective amount of a somatostatin analog containing six or more amino acids.
REFERENCES:
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4395403 (1983-07-01), Bauer et al.
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4650787 (1987-03-01), Schally et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
The Merck Manual of Diagnosis and Therapy, 11.sup.th Ed., pp. 1451-1453, (1966).
Souqruet, Cancer, vol. 59(9), pp. 1654-1660 (May 1, 1987).
Altman et al., Archives of Dermatology, 125:2-3, Mar. 1989.
Cai, R. -Z., et al., Proc. Natl. Acad. Sci., 83:1896-1900 (1986).
Camisa, C., et al., Cleveland Clinic Journal of Medicine, 57(1):71-76 (1990).
Choi, Hoo-Kyun, et al., Pharmaceutical Research, 7(11):1099-1106 (1990).
Karashima, T., et al., Life Sciences, 41:1011-1019 (1987).
Neely, E.K., et al., J. Inv. Dermatol., 96(1):104-110 (Jan. 1991).
Redding, T.W. et al., Proc. Natl. Acad. Sci., 80:1078-82 (1983).
Reubi, J.C. et al., Arch. Dermatol. Res. 282:139-141 (1990).
Schally, A.V., et al., Proc. Natl. Acad. Sci. USA, 84:7275-729 (1987).
Setyono-Han, B. et al., Cancer Research, 47:1566-1569 (1987).
Siegel, R.A., et al., Cancer Research, 48:4651-4655 (1988).
Veber, Daniel F., et al., Life Sciences, 34:1371-1378 (1984).
Bogden Arthur E.
Moreau Jacques-Pierre
Biomeasure Inc.
MacMillan Keith D.
Morrill, Esq Brian R.
Wessendorf T. D.
LandOfFree
Method for treating benign and malignant proliferative skin dise does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating benign and malignant proliferative skin dise, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating benign and malignant proliferative skin dise will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542496